logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Frank Struyf

Janssen Research and Development
H指数:44
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

SARS-CoV-2变异株抗体反应的免疫相关性分析：ENSEMBLE疫苗有效性试验

iScience
IF4.1
2025-09-290
OAAI
Alex Luedtke; Youyi Fong; Lars van der Laan; Fei Heng; Ying Huang; Yiwen Lu; Chenchen Yu; Lindsay N. Carpp; Sanne Roels; Mathieu Le Gars; Griet A. Van Roey; Daniel J. Stieh; Ilse Van Dromme; Avi Kenny; Marco Carone; Ollivier Hyrien; Victor Ayala; Lakshmi Jayashankar; Flora Castellino; Obrimpong Amoa-Awua; Manjula Basappa; Britta Flach; Bob C. Lin; Christopher Moore; Mursal Naisan; Muhammed Naqvi; Sandeep Narpala; Sarah O’Connell; Allen Mueller; Leo Serebryannyy; Mike Castro; Jennifer Wang; Gabrielle Dziubla; April K. Randhawa; Michele P. Andrasik; Jenny Hendriks; Carla Truyers; Frank Struyf; Hanneke Schuitemaker; Macaya Douoguih; James G. Kublin; Lawrence Corey; Kathleen M. Neuzil; Linda-Gail Bekker; Nigel Garrett; Sandra W. Cardoso; Patrice DelaFontaine; Craig A. Magaret; Johan Vingerhoets; Martin Casapia; Marcelo H. Losso; Susan J. Little; Aditya Gaur; Edith Swann; Christos J. Petropoulos; Adrian B. McDermott; Jerald Sadoff; Glenda E. Gray; Beatriz Grinsztejn; Paul A. Goepfert; Dean Follmann; Pavitra Roychoudhury; Alexander L. Greninger; Richard A. Koup; Ruben O. Donis; Peter B. Gilbert
Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy

妊娠期接种腺病毒载体COVID-19疫苗后，母亲和婴儿的安全、免疫原性及妊娠结局

Human Vaccines & Immunotherapeutics
IF3.5
2025-08-130
PRE
Gloria Aguilar; Gabriela Tapia-Calle; Cynthia Robinson; Benoit Baron; David Lowson; Bassem Maximos; Veronica V. Rezelj; Anne Marit de Groot; Nicole Bet; Vitalija van Paassen; Mathieu Le Gars; Frank Struyf; Javier Ruiz-Guiñazú
Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines

两种腺病毒载体COVID-19疫苗后疫苗诱导的免疫性血小板减少症和血栓形成病例的比较

Communications Medicine
IF6.3
2025-05-100
OAAI
Rian Van Rampelbergh; Sue Pavord; Luis Anaya-Velarde; Vitalija van Paassen; Karin Hardt; Emiliano Tatar; Javier Ruiz-Guiñazú; Dawn Baumgardner; Valérie Oriol Mathieu; Nicolas Praet; Hendy Kristyanto; Jerald Sadoff; Macaya Douoguih; Yimei Xu; Frank Struyf
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial

安全性、反应原性和免疫原性：Ad26.COV2.S 与四价标准剂量或高剂量季节性流感疫苗联合接种：一项非劣效性随机对照试验

ECLINICALMEDICINE
IF10
2025-01-010
OAAI
Tapia-Calle, Gabriela; Aguilar, Gloria; Vaissiere, Nathalie; Truyers, Carla; Ylisastigui, Pedro; Buntinx, Erik; Le Gars, Mathieu; Struyf, Frank; Scheper, Gert; Douoguih, Macaya; Ruiz-Guinazu, Javier
Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial

不同剂量水平的ad26.cov2.s作为新型冠状病毒肺炎疫苗初治健康成人的2剂量方案的安全性和体液免疫原性: 一项3期随机临床试验

VACCINES
IF3.4
2024-10-030
OAAI
Rezelj, Veronica V.; Paddenburg, Fred; Diegbe, Marie Enajite; Nangosyah, Julius; Reisinger, Emil C.; Hu, Weihong; Truyers, Carla; Scheper, Gert; Le Gars, Mathieu; Hendriks, Jenny; Struyf, Frank; Douoguih, Macaya; Schuitemaker, Hanneke; Ruiz-Guinazu, Javier
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials

在4项3期试验中SARS-CoV-2病毒载量与新型冠状病毒肺炎疫苗接种之间的关联

JOURNAL OF INFECTIOUS DISEASES
IF4.5
2024-09-032
OA
Janes, Holly; Fisher, Leigh H.; Kee, Jia Jin; Parameswaran, Lalitha; Goepfert, Paul A.; Falsey, Ann R.; Ludwig, James; Magaret, Craig A.; Gilbert, Peter B.; Kublin, James G.; Rouphael, Nadine; Sobieszczyk, Magdalena E.; El Sahly, Hana M.; Baden, Lindsey R.; Grinsztejn, Beatriz; Walsh, Stephen R.; Gray, Glenda E.; Kotloff, Karen L.; Gay, Cynthia L.; Greninger, Alexander L.; Tapia, Milagritos D.; Hammershaimb, E. Adrianne; Priddy, Frances H.; Green, Justin A.; Struyf, Frank; Dunkle, Lisa; Neuzil, Kathleen M.; Corey, Lawrence; Huang, Yunda
Risk of COVID-19 after natural infection or vaccination

自然感染或接种疫苗后新型冠状病毒肺炎的风险

EBIOMEDICINE
IF10.8
2023-10-012
OAAI
Rick, Anne-Marie; Laurens, Matthew B.; Huang, Ying; Yu, Chenchen; Martin, Thomas C. S.; Rodriguez, Carina A.; Rostad, Christina A.; Maboa, Rebone M.; Baden, Lindsey R.; El Sahly, Hana M.; Grinsztejn, Beatriz; Gray, Glenda E.; Gay, Cynthia L.; Gilbert, Peter B.; Janes, Holly E.; Kublin, James G.; Huang, Yunda; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M.; Neuzil, Kathleen M.; Corey, Lawrence; Goepfert, Paul A.; Walsh, Stephen R.; Follmann, Dean; Kotloff, Karen L.
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

Ad26.cov2.s新型冠状病毒肺炎疫苗加强方案的疗效，安全性和免疫原性 (ENSEMBLE2): 一项随机，双盲，安慰剂对照的3期试验的结果

LANCET INFECTIOUS DISEASES
IF31
2022-12-0151
OAAI
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guinazu, Javier; Faust, Saul N.; Spinner, Christoph D.; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

呼吸道合胞病毒Prefusion F (RSVPreF3) 候选疫苗在老年人中的安全性和免疫原性: 1/2期随机临床试验

JOURNAL OF INFECTIOUS DISEASES
IF4.5
2022-07-2970
OAAI
Leroux-Roels, Isabel; Davis, Matthew G.; Steenackers, Katie; Essink, Brandon; Vandermeulen, Corinne; Fogarty, Charles; Andrews, Charles P.; Kerwin, Edward; David, Marie Pierre; Fissette, Laurence; Vanden Abeele, Carline; Collete, Delphine; de Heusch, Magali; Salaun, Bruno; De Schrevel, Nathalie; Koch, Juliane; Verheust, Celine; Dezutter, Nancy; Struyf, Frank; Mesaros, Narcisa; Tica, Jelena; Hulstrom, Veronica
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial
LANCET INFECTIOUS DISEASES
IF31
2022-07-0114
OAAI
Folschweiller, Nicolas; Vanden Abeele, Carline; Chu, Laurence; Van Damme, Pierre; Garcia-Sastre, Adolfo; Krammer, Florian; Nachbagauer, Raffael; Palese, Peter; Solorzano, Alicia; Bi, Dan; David, Marie-Pierre; Friel, Damien; Innis, Bruce L.; Koch, Juliane; Mallett, Corey P.; Rouxel, Ronan Nicolas; Salaun, Bruno; Vantomme, Valerie; Verheust, Celine; Struyf, Frank

研究方向

暂未获取到该数据
G
Gary Dubin
H 指数:56论文数:157被引数:1.7万
M
Mathieu Le Gars
H 指数:22论文数:95被引数:6,024
M
Macaya Douoguih
H 指数:33论文数:93被引数:7,691
H
Hanneke Schuitemaker
H 指数:88论文数:456被引数:3.0万
S
S. Rachel Skinner
H 指数:45论文数:216被引数:1.0万
M
Matti Lehtinen
H 指数:70论文数:489被引数:2.3万
D
Dominique Descamps
H 指数:41论文数:122被引数:9,165
D
Dan Apter
H 指数:61论文数:231被引数:1.3万
B
Barbara Romanowski
H 指数:35论文数:106被引数:9,333
J
Jerald Sadoff
H 指数:75论文数:259被引数:2.4万